ADMA Biologics, Inc. (NASDAQ: ADMA) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT ADMA BIOLOGICS, INC.

ADMA Biologics, Inc. (NASDAQ: ADMA)
Listen to this Section


$7.97
-0.0150 ( -0.19% ) 1.1M

ADMA Biologics Inc is an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics for the treatment of immunodeficient patients at risk for infection and others at risk for certain infectious diseases. The segments of the company are ADMA BioManufacturing which generates maximum revenue and Plasma Collection Centres, and corporate segment. The company sells plasma-derived intermediate fractions to certain customers, which are generated as part of its FDA-approved manufacturing process for IG and IVIG products. It also provides laboratory contracting services to certain customers and anticipates providing contract filling, labeling and packing services. The company derives maximum revenue from United States.

Market Data


Open $7.97
Previous Close $7.98
Volume 1.1M
Market Cap $1.85B
Day Range $7.92 - $8.15
52 Week Range $7.21 - $22.37
Shares Outstanding 231.77M
Change % -0.19%
Net Change ▼ -0.0150
Insider Ownership N/A
Exchange NASDAQ
SectorBasic Materials
IndustryBIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
IPO Year2013
CountryUnited States

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
10-q Quarterly Reports 74 Nov 05, 2025
8-k 8K-related 14 Nov 05, 2025
4 Insider transactions 1 Oct 24, 2025
4 Insider transactions 1 Sep 16, 2025
4 Insider transactions 1 Aug 15, 2025
10-q Quarterly Reports 79 Aug 06, 2025
8-k 8K-related 16 Aug 06, 2025
4 Insider transactions 1 Aug 01, 2025
4 Insider transactions 1 Jul 28, 2025
4 Insider transactions 1 Jul 28, 2025

Latest News


× Before browsing our site, please accept our cookies policy